Prostate cancer is a complicated and multi-headed beast, and doctors are constantly looking for any new edge, and new weapon that science can provide. Scientists at The Wistar Institute were not able to contribute a new bullet to The Cause – but they did find a new Achilles' heel at which to shoot.
Read MoreA study that tracked midlife and older men for more than 20 years has found that vigorous exercise and other healthy lifestyle habits may cut their chances of developing prostate cancer by up to 68 percent.
Read MoreDoctors have long known that obesity has direct consequences on health and is associated with the onset of aggressive cancers, but the mechanisms underlying this phenomenon are little known.
Read MoreScientists have engineered a sort of “biological barbell” that can get inside cancer cells and do damage to two proteins that work independently and together to enable cancer's survival and spread.
Read MoreBack in October 2015, OncoGenx announced a phase 3 trial designed to evaluate whether the investigational treatment custirsen, when combined with cabazitaxel, improves survival in men with metastatic castrate-resistant prostate cancer.
Read MoreCancer researchers have applied a comprehensive set of analytical tools to lethal cases of metastatic prostate cancer, yielding a detailed map of the complex networks of interactions among genes and proteins that enable prostate cancer cells to proliferate and evade treatment.
Read MoreA newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy.
Read MoreThe potential foundation for a next-generation therapy, called tetraaryl cyclobutane, or CB, is being studied as an option for prostate tumors that have grown resistant to current anti-androgen drugs, notably enzalutamide.
Read MoreCancer researchers have developed a computational approach for analyzing patient-specific data to help doctors choose the most effective drugs for individual patients.
Read MoreMost men like a plan of action and here is a dietary plan all men should embrace that could curtail their chance of developing prostate cancer.
Read MoreAlthough it reads like European license plate number, a protein known as ZMYND8 has demonstrated its ability to block metastasis-linked genes in prostate cancer.
Read MoreIn the study published in the journal Oncotarget, 10 men with metastatic prostate cancer resistant to androgen deprivation therapy and the androgen receptor antagonist enzalutamide were treated with pembrolizumab, a monoclonal antibody that binds to the PD-1 receptor.
Read More
